0.7% identified as Aboriginal and/or Torres Strait Islander
64.7% female; 35.3% male
136 notifications lodged with Ahpra about
5 immediate actions taken
17 mandatory notifications received
36 practitioners monitored for health, performance and/or conduct during the year
47 cases being monitored at 30 June:
15 criminal offence complaints made
3 matters decided by a tribunal
No matters decided by a panel
1 appeal lodged
The Physiotherapy Board of Australia continued to
make progress on our strategic work. The Board’s
primary concern was the workforce issues created
by the ongoing pandemic. To address these, it has
supported the scheme-wide response strategies,
such as the pandemic sub-register. The Board started
to meet in person again in March, with a combination
of face-to-face and online meetings.
The Board continued to respond to the needs of the
profession, healthcare services and the public by
modifying the regulatory approach to support the
profession through the pandemic. A flexible approach
to continuing professional development and recency
of practice requirements was maintained.
This work included enabling the continuing
registration of physiotherapists on the pandemic subregister
to give additional support for the COVID-19
surge workforce and vaccination roll-out.
The Board released the cross-profession
Supervised practice framework.
The Board has continued to work with the New
Zealand Physiotherapy Board on a first review of
the bi-national practice thresholds, with a focus on
updating the wording in relation to cultural safety
and digital competence.
The Board released a revised Code of conduct
in partnership with several other Boards.
Given the ongoing and fluctuating travel
restrictions, the Board relied mostly on online
engagement methods. It held a series of webinars on
physiotherapy and non-medical prescribing to gain a
shared understanding of this concept.
The Board valued increased engagement and
partnership with its stakeholders, including the
Australian Physiotherapy Association, the Australian
Physiotherapy Council, the NSW Physiotherapy
Council and the Council of Physiotherapy Deans
of Australia and New Zealand (CPDANZ). These
partnerships have been critical to our pandemic
response and remain pertinent to moving our
strategic projects forward.
The Board further developed a background paper,
building on a literature review and exploration
report previously completed, on whether to endorse
prescribing for physiotherapists. Due to COVID-19
restrictions, the Board conducted webinars to
explore this concept further. We shared the paper
with key stakeholders and received significant
feedback. The next step is to engage with key
stakeholders in person via a forum.
Following its workforce analysis work last year
and given COVID's impact on the healthcare
workforce, the Board is committed to exploring
and understanding the physiotherapy workforce,
practitioner wellbeing and the factors that influence it.
Ms Kim Gibson